Ptc Therapeutics (PTCT) Inventory (2017 - 2026)

Ptc Therapeutics' Inventory history runs 10 years deep, the most recent figure standing at $91.4 million for Q2 2026.

• In Q2 2026, Inventory rose 168.21% year-over-year to $91.4 million; the TTM figure through Jun 2026 stood at $91.4 million (up 168.21% YoY), while the FY2025 annual figure was $79.6 million, up 243.39% from the prior year.
• Inventory for Q2 2026 stood at $91.4 million, up from $75.6 million in the prior quarter.
• The five-year high for Inventory was $91.4 million in Q2 2026, with the low at $14.8 million in Q3 2022.
• The 5-year median for Inventory is $31.2 million (2023), against an average of $37.1 million.
• The sharpest annual moves came in 2025 and 2026: Inventory decreased 27.89% in 2025, then soared 248.64% in 2026.
• Ptc Therapeutics' Inventory stood at $21.8 million in 2022, then jumped by 40.21% to $30.6 million in 2023, then dropped by 24.15% to $23.2 million in 2024, then soared by 243.39% to $79.6 million in 2025, then gained by 14.7% to $91.4 million in 2026.
• Business Quant data shows PTCT's Inventory at $91.4 million in Q2 2026, $75.6 million in Q1 2026, and $79.6 million in Q4 2025.